National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

autologous expanded mesenchymal stem cells OTI-010
Multipotent self-renewing adherent non-hematopoietic stromal cells harvested from a patient's bone marrow and grown in vitro. When injected back into the patient, autologous expanded mesenchymal stem cells OTI-010 may differentiate into various mesenchyme-derived cell types and, in some instances, may augment bone marrow engraftment after whole-body irradiation. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

US brand name:Stromagen
Code name:OTI-010



Previous:autologous dinitrophenyl-modified ovarian cancer vaccine, autologous EBV-CTL CD19CAR zeta, autologous EBV-transformed B lymphoblastoid-tumor fusion cell vaccine, autologous Epstein-Barr virus-specific cytotoxic T lymphocytes, autologous Epstein-Barr virus-transformed B-lymphoblastoid cell vaccine
Next:autologous heat-shock protein 70 peptide vaccine AG-858, autologous immunoglobulin idiotype-KLH conjugate vaccine, autologous LMP1-/LMP2- specific cytotoxic T-lymphocytes, autologous OFA-iLRP RNA-transfected dendritic cell vaccine, autologous PBTL CD19CAR-28 zeta

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov